Home/Filings/4/0000950170-25-013516
4//SEC Filing

CARR EDWARD 4

Accession 0000950170-25-013516

CIK 0001690585other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:27 PM ET

Size

5.5 KB

Accession

0000950170-25-013516

Insider Transaction Report

Form 4
Period: 2025-02-03
CARR EDWARD
CHIEF ACCOUNTING OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-03+60,00060,000 total
    Exercise: $22.07Exp: 2035-02-02Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Documents

1 file

Issuer

Dianthus Therapeutics, Inc. /DE/

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001273351

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:27 PM ET
Size
5.5 KB